Microvascular endothelial system

The microvascular endothelial system is a complex, highly specialized network of cells lining the smallest blood vessels, including arterioles, capillaries, and venules. It functions as a semi-permeable barrier and a dynamic endocrine organ that regulates vascular tone, blood pressure, and the exchange of nutrients and waste between blood and tissues (StatPearls: NBK554417). Beyond its structural role, the endothelium is central to hemostasis, inflammatory responses, and the formation of new blood vessels through angiogenesis (PubMed: 17684518). Dysfunction of the microvascular endothelium is a primary driver in the progression of chronic conditions such as atherosclerosis, hypertension, and diabetic microangiopathy (NIH: PMC3143075). While the system itself is not a single molecular target, it expresses numerous receptors and enzymes, such as vascular endothelial growth factor receptors (VEGFRs) and endothelial nitric oxide synthase (eNOS), which are major therapeutic targets (PubMed: 25634015). Drugs like bevacizumab target endothelial signaling to inhibit tumor angiogenesis, while others like ACE inhibitors aim to improve overall endothelial health and vasodilation (PubChem: CID 60852).

Other names

MicrovasculatureVascular endotheliumEndothelial systemMicrovascular bed

Pharmacological agents interact with the microvascular endothelial system by targeting specific molecular components, such as inhibiting VEGF receptors to prevent angiogenesis or stimulating nitric oxide production to induce vasodilation (PubMed: 25634015, PubChem: CID 60852).